Weight Loss Drugs May Reduce Alcohol Consumption, Study Finds
New research from Virginia Tech indicates that medications used for weight loss, known as GLP-1 agonists, may also help individuals reduce their alcohol intake by altering how the body processes alcohol.
The study reveals these drugs affect alcohol absorption similarly to how they impact food digestion, slowing the movement of substances from the stomach to the small intestine. This delay means it takes longer for individuals to feel the effects of alcohol, potentially diminishing its appeal. Excessive alcohol use is a significant public health concern, contributing to numerous chronic diseases.
“Delayed rewards just aren’t as good as immediate ones,” explained Alex DiFeliceantonio, an assistant professor in Virginia Tech’s department of human nutrition, foods and exercise, and co-author of the study. The research showed consistent results across different GLP-1 agonist medications, suggesting the effect isn’t specific to a single drug. Understanding the neurobiology of addiction is crucial for developing effective treatments; you can learn more about the National Institute on Alcohol Abuse and Alcoholism.
DiFeliceantonio noted the potential implications for treating alcohol use disorder, stating, “We don’t really have a lot of great treatments for alcohol use disorder. Relapse is very common. Maybe these drugs could be useful for helping people who really want to cut back on their drinking.” Further research is planned to explore these findings and determine if GLP-1 agonists could be repurposed as a tool in addiction treatment, building on existing Substance Abuse and Mental Health Services Administration resources.
Researchers will continue to investigate the long-term effects and potential therapeutic applications of these drugs in relation to alcohol consumption.
